Sight Sciences, Inc.
NASDAQ:SGHTMedical - Devices
Healthcare
$10.62 +2.89%
+$0.15 today
- Market cap
- $590.25M
- Beta
- 2.41
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$0.69
52W Low $3.11High $9.24
Volume 0.38M
Average 0.25M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$29.69M
FY 2025 · Annual
Investing Cash Flow
-$224,000.00
FY 2025 · Annual
Financing Cash Flow
$1.79M
FY 2025 · Annual
-63.9% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (62.96M) | (86.24M) | (55.55M) | (51.51M) | (38.43M) |
| Depreciation & Amortization | 632K | 710K | 614K | 712K | 487K |
| Deferred Income Tax | 7.76M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 5.08M | 12.96M | 14.58M | 17.08M | 13.05M |
| Change in Working Capital | (4.33M) | (5.7M) | (9.13M) | 9M | (6.4M) |
| Accounts Receivables | (3.69M) | (6.84M) | 661K | 3.55M | 912K |
| Inventory | (1.31M) | (3.25M) | (2.16M) | 1.63M | (1.44M) |
| Accounts Payables | 1.17M | (694K) | (883K) | 336K | (348K) |
| Other Working Capital | (486K) | 5.09M | (6.76M) | 3.49M | (5.52M) |
| Other Non-Cash Items | 1.27M | 2.3M | 2.3M | 2.37M | 1.59M |
| Operating Cash Flow | (52.54M) | (75.97M) | (47.18M) | (22.35M) | (29.69M) |
| Capital Expenditures | (813K) | (970K) | (791K) | (385K) | (224K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (813K) | (970K) | (791K) | (385K) | (224K) |
| Debt Repayment | 0 | 0 | 0 | 4.15M | 0 |
| Common Stock Issued | 256.68M | 1.25M | 1.33M | 1.07M | 1.85M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.15M) | 1.25M | (224K) | (261K) | (58K) |
| Financing Cash Flow | 252.53M | 1.25M | 1.1M | 4.96M | 1.79M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 199.18M | (75.69M) | (46.87M) | (17.77M) | (28.13M) |
| Free Cash Flow | (53.35M) | (76.94M) | (47.98M) | (22.74M) | (29.92M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$38.4M
+ D&A$487.0K
+ Stock-Based Comp$13.1M
+ Deferred Tax$0
- Working Capital-$6.4M
+ Other Non-Cash$1.6M
= Operating Cash Flow-$29.7M
- Capex-$224.0K
= Free Cash Flow-$29.9M
Analysis
FY2025 free cash flow is -$29.9M. FCF conversion is 77.9% of net income. Operating cash flow was -$29.7M, with capex of -$224.0K. The largest bridge item is Stock-Based Comp at $13.1M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 |
Does SGHT generate free cash flow?
Sight Sciences, Inc. (SGHT) generated -$29.92M of free cash flow in fiscal 2025.
How much operating cash flow does SGHT produce?
Operating cash flow was -$29.69M, before capital expenditures of $224,000.00.
Continue the stock analysis
Jump to another research area for this company.